BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 13
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 24
• 25
• 28
• 29
• 30

• Press Releases

  Neuronetics to Report First Quarter 2025 Financial and Operating Results and Host Conference Call

  April 22, 2025

   · 

  1 min read
• Press Releases

  Genprex Announces Research Collaborators’ Abstract Published in Cancer Research Supplement Proceedings

  April 22, 2025

   · 

  8 min read
• Press Releases

  EditCo Bio and Promega Partner to Power a New Era of Biologically Relevant Cell-Based Research

  April 22, 2025

   · 

  3 min read
• Press Releases

  Nucleai Launches First-of-its-Kind Deep Learning Model to Automate Spatial Proteomics, Accelerating Biomarker Discovery for ADCs, Bispecifics, and Immunotherapy

  April 22, 2025

   · 

  6 min read
• Press Releases

  Veracyte Announces Multiple Abstracts Demonstrating Power of Decipher Testing To Fuel New Prostate and Bladder Cancer Insights Will Be Presented at AUA Annual Meeting

  April 22, 2025

   · 

  8 min read
• Press Releases

  Cycle Pharmaceuticals Launches Cycle Vita PKU™, an AI-Powered Smartphone App for On-The-Go Management of Phenylketonuria (PKU)

  April 22, 2025

   · 

  2 min read
• Press Releases

  Oncotelic CEO Vuong Trieu to Present Innovative “Deciparticles” Platform at IDDST-Europe 2025 Conference in Stockholm

  April 22, 2025

   · 

  5 min read
• Press Releases

  Cohen Milstein Calls on Zenas BioPharma (ZBIO) Investors to Act Following Significant Post-IPO Losses

  April 22, 2025

   · 

  2 min read
• Press Releases

  Secretome Therapeutics Appoints Dr. Marshelle Smith Warren as Chief Medical Officer

  April 22, 2025

   · 

  2 min read
• Press Releases

  Andrew Taylor joins Novonesis’ Executive Leadership Team

  April 22, 2025

   · 

  1 min read